AI scribes: Efficiency for whom?
Objective:
To evaluate the adoption of AI scribes in healthcare and address the associated ethical, clinical, and regulatory concerns, including accuracy, bias, and privacy.
Key Findings:
- AI scribes can generate inaccuracies that compromise patient safety and trust.
- They often fail to capture nuances of human communication, leading to potential bias and misinterpretation.
- Privacy risks are heightened due to cloud storage and third-party involvement, which may expose sensitive patient information.
Interpretation:
The implementation of AI scribes is occurring without sufficient empirical evidence of their benefits, raising significant concerns about their potential negative impact on patient care and documentation integrity.
Limitations:
- Limited empirical evaluation of AI scribes prior to widespread adoption, raising questions about their reliability.
- Concerns about over-capture of information that may obscure important clinical details, such as critical symptoms or patient history.
Conclusion:
There is a pressing need for regulatory frameworks and quality assurance measures to ensure AI scribes align with healthcare goals and do not compromise patient safety, privacy, or the integrity of clinical documentation.
AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.